<DOC>
	<DOCNO>NCT01800032</DOCNO>
	<brief_summary>This prospective pilot study design provide preliminary data use Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging ( FDG-PET-MRI ) patient neurofibromatosis-1 ( NF1 ) associate optic glioma plexiform neurofibroma ( PN ) . Subjects undergo FDG-PET-MRI scan place standard care image 0 12 month , unless frequent image clinically indicate . Subjects family caregiver also undergo serial interview complete questionnaire relate psychosocial aspect NF1 .</brief_summary>
	<brief_title>PET/MRI CNS Extra-CNS Tumors Patients With Neurofibromatosis-1 ( NF1 )</brief_title>
	<detailed_description />
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<mesh_term>Neurofibroma , Plexiform</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Optic Nerve Glioma</mesh_term>
	<criteria>Diagnosed neurofibromatosis1 either optic glioma , due image scan , plexiform neurofibroma , due image secondary clinical sign symptom progressive disease â‰¥ 6 year age Englishspeaking If female childbearing potential , negative urine pregnancy test perform within 7 day prior FDGPETMRI Studyspecific inform consent assent obtain sign Unable undergo FDGPETMRI without sedation Currently undergo chemotherapy progress optic glioma Pregnant lactate female Poorly control diabetes mellitus Presence pacemaker , intracranial aneurysm clip , cochlear implant , metal halo device , epicardial pacemaker lead , device make MRI unsafe Serum creatinine &gt; 1.8 mg/dL OR GFR &lt; 30 mL/min Unable lie flat &gt; 1 hour Body Mass Index ( BMI ) &gt; 35</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>